Project 4: needs approval from authorities
Working title: “GYNGENIN”
Therapeutic Area: Gynecology, Life-style preparation
Application Form: Lube, vaginal creme
Route of Administration: intravaginally
Probability of Realization: medium to high
Daily 8-PN dose (mg): 0.1 contained in 2.5 g crème (40µg 8-PN/g crème)
Scientific Basis: The effective area dose of 1 µg/cm² is derived from skin studies (Skin area dose was lowered by a factor of 2 because of expected higher rate and degree of absorption through the slightly damaged and mostly dry mucous membrane)
Time to Market (best guess): 2-3 years